Related Experiment Video

Updated: May 2, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.0K

BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials

Zunairah Shah1, Sumbal Aziz2, Mariam Haji1

  • 11Roswell Park Comprehensive Cancer Center, Buffalo, NY.

Journal of the National Comprehensive Cancer Network : JNCCN
|April 30, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

892
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

17.0K

Related Experiment Videos

Last Updated: May 2, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.0K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

892
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

17.0K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

Articles linked to this work by shared authors, journal, and citation graph.

Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.

Journal of the National Cancer Institute·2026

The clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status.

NPJ breast cancer·2026

TP53 mutation is associated with shorter treatment duration with CDK4/6 inhibitors, but not with immune checkpoint inhibitors, in ER-positive/HER2-negative breast cancer: real-world perspective.

Breast cancer research : BCR·2026

Brain tumor segmentation in Sub-Saharan Africa patient population: The BraTS-Africa challenge.

Neuro-oncology advances·2026

Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.

American journal of clinical oncology·2026

The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond.

Nature reviews. Drug discovery·2026

Neighborhood Poverty and End-of-Life Care Among Adolescents and Young Adults With Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

What is Optimal Neoadjuvant Therapy in HER2-Positive Breast Cancer?

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Primary Localized Amyloidosis of the Urinary Bladder Mimicking Urothelial Carcinoma: A Case Report.

Cureus·2026

Liver-specific gene therapy based on self-complementary adeno-associated virus for lysosomal acid lipase deficiency.

Frontiers in pharmacology·2026

Experimental evidence of electroacupuncture in ALS mouse models: a systematic review and meta-analysis.

Frontiers in neurology·2026

Prospective Observational Study: Congruence of Fine-needle Aspiration Cytology and Histopathological Report in Thyroid Swellings in a Tertiary Hospital Setting.

Annals of African medicine·2026

Real-World Luspatercept Evidence in Myelodysplastic Neoplasms: A Systematic Review and Bayesian Meta-Analysis.

Hematological oncology·2026

Minimally invasive and robotic-assisted excision of intracardiac masses: a single-center retrospective study.

Journal of cardiothoracic surgery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us